Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Realyze Intelligence
Pittsburgh, Pennsylvania, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Realyze’s AI platform has shown to match nearly 7x more patients to oncology trials and double trial enrollment rates versus manual processes in clinical deployments at UPMC Hillman Cancer Center
- Therapeutic areas
- GastroenterologyNephrologyOncologyEndocrinology
- Modalities
- Non-pharmacological therapy
- Industry
- Biomedical IT and Biomedical Data Platforms
02
Partnerships
UPMC Hillman Cancer CenterMemorial Sloan Kettering Cancer Center Innovation HubQ-Centrix (clinical data management partnership in 2022)CancerX Accelerator Program
Beyond the preview
Go deeper on Realyze Intelligence.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Realyze Intelligence.